Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (211-220 of 261) with videos related to

Pageof 27
Sort By:
Cancer|July 4, 2013
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter studyAndreas A Argyriou, Guido Cavaletti, Anna Antonacopoulou, et al.
Neurobiology of Disease|December 4, 2017
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growthLawrence Van Helleputte, Mandy Kater, Dana P Cook, et al.
Plos One|October 12, 2017
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insightsPaola Marmiroli, Beatrice Riva, Eleonora Pozzi, et al.
Journal of Pain and Symptom Management|July 27, 2017
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal CancerKathleen A Griffith, Shijun Zhu, Meg Johantgen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 10, 2009
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseasesLuca Padua, Chiara Briani, Stefano Jann, et al.
Journal of the Peripheral Nervous System : JPNS|April 11, 2015
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysisSalvatore Terrazzino, Andreas A Argyriou, Sarah Cargnin, et al.
European Journal of Medicinal Chemistry|September 18, 2018
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agentsMarta Rui, Giacomo Rossino, Stefania Coniglio, et al.
American Journal of Hematology|August 28, 2014
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 studyPaola Tacchetti, Carolina Terragna, Monica Galli, et al.
Journal of Neuroimmunology|June 17, 2020
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathyGiuseppe Liberatore, Claudia Giannotta, Blesson Punnen Sajeev, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
Pageof 27

Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Cancer|July 4, 2013
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter studyAndreas A Argyriou, Guido Cavaletti, Anna Antonacopoulou, et al.
Neurobiology of Disease|December 4, 2017
Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growthLawrence Van Helleputte, Mandy Kater, Dana P Cook, et al.
Plos One|October 12, 2017
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insightsPaola Marmiroli, Beatrice Riva, Eleonora Pozzi, et al.
Journal of Pain and Symptom Management|July 27, 2017
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal CancerKathleen A Griffith, Shijun Zhu, Meg Johantgen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 10, 2009
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseasesLuca Padua, Chiara Briani, Stefano Jann, et al.
Journal of the Peripheral Nervous System : JPNS|April 11, 2015
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysisSalvatore Terrazzino, Andreas A Argyriou, Sarah Cargnin, et al.
European Journal of Medicinal Chemistry|September 18, 2018
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agentsMarta Rui, Giacomo Rossino, Stefania Coniglio, et al.
American Journal of Hematology|August 28, 2014
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 studyPaola Tacchetti, Carolina Terragna, Monica Galli, et al.
Journal of Neuroimmunology|June 17, 2020
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathyGiuseppe Liberatore, Claudia Giannotta, Blesson Punnen Sajeev, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
Pageof 27